CONTICINI, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 7.355
EU - Europa 7.348
AS - Asia 5.714
SA - Sud America 970
AF - Africa 337
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 21.744
Nazione #
US - Stati Uniti d'America 7.143
RU - Federazione Russa 2.117
IT - Italia 2.106
SG - Singapore 2.083
CN - Cina 1.301
BR - Brasile 814
IE - Irlanda 617
VN - Vietnam 562
GB - Regno Unito 535
DE - Germania 516
HK - Hong Kong 466
KR - Corea 346
FR - Francia 338
FI - Finlandia 315
BD - Bangladesh 267
SE - Svezia 240
IN - India 227
NL - Olanda 158
ZA - Sudafrica 152
CA - Canada 118
JP - Giappone 88
CI - Costa d'Avorio 70
PL - Polonia 65
ES - Italia 64
IQ - Iraq 63
MX - Messico 56
AR - Argentina 52
CZ - Repubblica Ceca 47
TR - Turchia 40
UA - Ucraina 40
AT - Austria 39
CH - Svizzera 35
KE - Kenya 34
ID - Indonesia 31
EC - Ecuador 30
IR - Iran 25
UZ - Uzbekistan 25
PK - Pakistan 23
VE - Venezuela 22
MA - Marocco 18
AE - Emirati Arabi Uniti 17
EG - Egitto 17
LT - Lituania 16
SA - Arabia Saudita 16
NG - Nigeria 14
CL - Cile 13
MY - Malesia 13
NP - Nepal 13
PH - Filippine 13
PY - Paraguay 13
AU - Australia 12
BE - Belgio 11
CO - Colombia 11
IL - Israele 10
EE - Estonia 9
PT - Portogallo 9
JM - Giamaica 8
JO - Giordania 8
LB - Libano 8
RO - Romania 8
TN - Tunisia 8
AZ - Azerbaigian 7
BY - Bielorussia 7
ET - Etiopia 7
GR - Grecia 7
KZ - Kazakistan 7
UY - Uruguay 7
AM - Armenia 6
BG - Bulgaria 6
DK - Danimarca 6
MK - Macedonia 6
OM - Oman 6
TW - Taiwan 6
AL - Albania 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
HR - Croazia 5
HU - Ungheria 5
KG - Kirghizistan 5
PE - Perù 5
PS - Palestinian Territory 5
QA - Qatar 5
SN - Senegal 5
CY - Cipro 4
DZ - Algeria 4
EU - Europa 4
HN - Honduras 4
NO - Norvegia 4
PA - Panama 4
GE - Georgia 3
LV - Lettonia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AO - Angola 2
BO - Bolivia 2
GT - Guatemala 2
LI - Liechtenstein 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PR - Porto Rico 2
Totale 21.713
Città #
Dallas 2.419
Singapore 1.497
Moscow 616
Dublin 600
Ashburn 538
Hefei 516
San Jose 514
Santa Clara 502
Hong Kong 439
Southend 355
Seoul 346
Munich 301
Siena 296
Milan 270
Beijing 259
Los Angeles 250
Helsinki 198
Chandler 197
Council Bluffs 194
Ho Chi Minh City 180
New York 170
Florence 152
Rome 145
Lauterbourg 142
Hanoi 135
Johannesburg 135
Fairfield 131
The Dalles 112
São Paulo 91
Bengaluru 87
Houston 73
Abidjan 70
Buffalo 67
Chicago 66
Redondo Beach 58
Orem 57
Princeton 57
Turku 56
Wilmington 54
Seattle 52
Warsaw 51
Lappeenranta 48
Tokyo 48
Woodbridge 47
Ann Arbor 46
Nuremberg 45
Cambridge 43
Montreal 42
London 41
Frankfurt am Main 40
Chennai 37
Shanghai 35
Toronto 34
Naples 32
Atlanta 29
Denver 29
Dong Ket 29
Brescia 28
Stockholm 28
Baghdad 27
Washington 27
Fremont 26
Rio de Janeiro 26
Boardman 25
Brooklyn 24
Portsmouth 24
Amsterdam 23
Düsseldorf 23
Olomouc 23
Vienna 23
Bologna 22
Da Nang 22
Málaga 22
Phoenix 22
Haiphong 21
Charlotte 20
San Francisco 20
Tashkent 20
Zurich 20
Guangzhou 19
Newark 19
Boston 18
Brno 18
Paris 18
Poplar 18
San Diego 18
Mumbai 17
Piscataway 17
Salt Lake City 16
Brasília 15
Manchester 15
Mexico City 15
San Mateo 15
Belo Horizonte 14
Cedar Knolls 14
Hyderabad 14
Turin 14
Istanbul 13
Livorno 13
Hillsboro 12
Totale 13.921
Nome #
A first update on mapping the human genetic architecture of COVID-19 582
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 577
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 515
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 504
Genetic mechanisms of critical illness in COVID-19 430
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 418
An explainable model of host genetic interactions linked to COVID-19 severity 371
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 356
Pathogen-sugar interactions revealed by universal saturation transfer analysis 355
Peripheral biomarkers' panel for severe COVID-19 patients 319
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 314
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 313
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 303
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 294
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 294
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 287
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 285
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 258
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 247
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 240
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 237
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 233
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 228
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 223
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 218
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 214
Doppler and Spectral Ultrasound of Sacroiliac Joints in Pediatric Patients with Suspected Juvenile Spondyloarthritis 207
Inflammatory muscle involvement in systemic vasculitis: A systematic review 206
WES profiling of COVID-19 206
Whole-genome sequencing reveals host factors underlying critical COVID-19 201
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol 198
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 198
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 197
The Advantages of Radiofrequency Echographic MultiSpectrometry in the Evaluation of Bone Mineral Density in a Population with Osteoarthritis at the Lumbar Spine 194
Clinical and molecular characterization of COVID-19 hospitalized patients 194
Baricitinib retention rate: ‘real-life’ data from a mono-centric cohort of patients affected by rheumatoid arthritis 191
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 191
Intramuscular Clodronate in Long-Term Treatment of Symptomatic Knee Osteoarthritis: A Randomized Controlled Study 190
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 187
Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study 182
Color Doppler Eye Ultrasonography in giant cell arteritis: differential diagnosis between arteritic and non-arteritic sudden blindness 181
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review 181
Diagnostic accuracy of OGUS, Southend halo score and halo count in giant cell arteritis 179
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 178
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 177
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 177
Novel laboratory markers for diagnosis and monitoring of ANCA associated vasculitis and idiopathic inflammatory myopathies interstitial lung disease 176
Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experience 175
Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy? 175
Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study 174
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab 172
Intra-articular injections of biological disease-modifying anti-rheumatic drugs in inflammatory arthropathies: An up-to-date narrative review 167
Adhesive capsulitis and ultrasound diagnosis, an inseparable pair: a novel review 167
The Role of Major Salivary Gland Ultrasound in the Diagnostic Workup of Sicca Syndrome: A Large Single-Centre Study 162
Diffuse Peripheral Enthesitis in Metabolic Syndrome: A Retrospective Clinical and Power Doppler Ultrasound Study 161
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 161
Low muscle mass and body composition analysis in a group of postmenopausal women affected by primary Sjögren’s syndrome 158
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 158
Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies 155
Relapse of microscopic polyangiitis after vaccination against COVID-19: a case report 155
Atypical Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Polymyalgia Rheumatica and Giant Cell Arteritis 152
Paraneoplastic arthritides: an up-to-date case-based systematic review 150
PD1, CTLA4 and TIGIT Expression on T and NK Cells in Granulomatous Diseases: Sarcoidosis and ANCA-Associated Vasculitis 149
KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach 149
Interstitial lung disease associated with psoriatic arthritis: a new disease entity? 148
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 146
Diagnostic role of minor salivary glands biopsy in Sjögren’s syndrome: correlations between histology and autoimmunity in a large, monocentric cohort 145
Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review 144
Magnetic resonance enterography in diagnosing and monitoring of adult-onset IgA vasculitis (Henoch-Schönlein purpura) with gastro-intestinal involvement: Report of two cases 141
Clinical spectrum of small-vessel vasculitis related to cocaine consumption: data from an Italian cohort 141
Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study 141
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 140
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 139
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 139
Polymyalgia rheumatica following infective triggers or vaccinations: A different subset of disease? 139
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 137
Bone-sparing effects of tocilizumab in rheumatoid arthritis: a monocentric observational study 136
UVA-1 phototherapy as adjuvant treatment for eosinophilic fasciitis: in vitro and in vivo functional characterization 136
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis 135
Polymyalgia Rheumatica: a syndrome with an enthesitic subset? Comment on: “Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice” by Marie Pean de Ponfilly–Sotier et al. Joint Bone Spine 2021;89:105325 134
Efficacy of intravenous neridronate in transient osteoporosis of the hip 130
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 128
Intravenous neridronate is effective in regional migratory osteoporosis 128
Safety and Efficacy of Long-Term Tocilizumab in a Cohort of Patients with Giant Cell Arteritis: An Italian Monocentric Retrospective Study 124
Power and spectral Doppler ultrasound in suspected active sacroiliitis: A comparison with magnetic resonance imaging as gold standard 121
Decrease in life expectancy due to COVID-19 disease not offset by reduced environmental impacts associated with lockdowns in Italy 120
Difference in pain and accuracy of two hyaluronic acid injection techniques for symptomatic knee osteoarthritis in overweight patients 119
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 119
Effects of antiresorptive agents on body composition: a case-control retrospective study 118
Immunological pathways in sarcoidosis and autoimmune rheumatic disorders—similarities and differences in an Italian prospective real-life preliminary study 117
Gitelman syndrome associated with chondrocalcinosis and severe neuropathy: A novel heterozygous mutation in SLC12A3 gene 115
Crowned dens syndrome presenting as hemiplegia and hypoesthesia 114
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 113
Validity of machine learning in predicting giant cell arteritis flare after glucocorticoids tapering 112
Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study 112
Idiopathic inflammatory myopathies: one year in review 2023 111
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study 111
Routine IgG4 staining in minor salivary gland biopsy in a cohort of Italian Caucasian patients suffering from xerostomia 109
High prevalence of ultrasound-defined enthesitis in patients with metabolic syndrome. Comment on: How normal is the enthesis by ultrasound in healthy subjects? Di Matteo et al 106
Immune-Checkpoint expression on CD4, CD8 and NK cells in blood, BAL and lymph nodes of sarcoidosis 105
Totale 19.919
Categoria #
all - tutte 70.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 0 86
2021/2022825 75 79 55 63 43 42 41 62 39 72 103 151
2022/20231.118 79 107 114 119 54 176 145 99 57 69 53 46
2023/20241.460 63 46 138 97 80 295 362 68 26 55 63 167
2024/20255.294 250 228 657 268 485 343 345 338 393 266 448 1.273
2025/202612.856 860 1.903 1.922 1.575 2.400 444 1.354 344 547 675 471 361
Totale 22.274